Joel Gelernter, MD
Cards
About
Titles
Foundations Fund Professor of Psychiatry and Professor of Genetics and of Neuroscience
Director, Division of Human Genetics (Psychiatry)Biography
Joel Gelernter, MD, is Foundations Fund Professor of Psychiatry and Professor of Genetics and Neurobiology; and Director, Division of Human Genetics (Psychiatry), at the Yale University School of Medicine.
The research focus of his laboratory is genetics of psychiatric illness – phenotypes including cocaine, opioid, nicotine, cannabis, and alcohol dependence, posttraumatic stress disorder (PTSD), depression, and panic and other anxiety disorders. He also studies a range of related phenotypes, including pharmacogenomics; and basic issues in population and complex trait genetics. The overall approach involves study of genetic polymorphism and sequence variation, on a molecular level and from the perspective of population genetics. Dr Gelernter’s laboratory published genomewide association studies (GWAS) for cocaine, cannabis, and opioid dependence, PTSD, alcohol dependence, nicotine dependence, and several related traits. All of these studies have resulted in the identification of novel risk loci.
Appointments
Psychiatry
ProfessorPrimaryNeuroscience
ProfessorSecondaryGenetics
ProfessorSecondary
Other Departments & Organizations
- Division of Neurocognition, Neurocomputation & Neurogenetics
- Center for Biomedical Data Science
- Center for the Translational Neuroscience of Alcohol
- Computational Biology and Biomedical Informatics
- Division of Human Genetics
- Division of Molecular Psychiatry
- Gelernter Lab
- Genetics
- Global Health Studies
- Molecular Cell Biology, Genetics and Development
- Neuroscience
- Neuroscience Research Training Program (NRTP)
- Office of Global Health Education
- Psychiatry
- Psychotherapy Development Center
- Stress & Addiction Clinical Research Program
- VA Alcohol Research Center
- VA-Yale Clinical Neurosciences PTSD Research Program
- Yale Center for Genomic Health
- Yale Center for the Science of Cannabis and Cannabinoids
- Yale Combined Program in the Biological and Biomedical Sciences (BBS)
- Yale Global Mental Health Program
- Yale Ventures
Education & Training
- Fellowship
- Psychiatric genetics, NIMH (1988)
- MD
- SUNY Downstate Medical Center (1983)
- BS
- Yale University, Music & Biology (1979)
Research
Overview
Medical Subject Headings (MeSH)
Academic Achievements and Community Involvement
Links & Media
Media
Depression GWAS results.
Levey et al Nat Neurosci. 2021 Jul;24(7):954-963.
News
- July 02, 2024
Na Chosen to Receive VA Career Development Award
- June 12, 2024
YSM, VA Researchers Complete First Genome-Wide Association Study of Epiretinal Membrane
- April 05, 2024Source: Molecular Psychiatry
Genetic Influences and Causal Pathways Shared Between Cannabis Use Disorder and Other Substance Use Traits
- March 20, 2024
From the journals
Get In Touch
Contacts
Psychiatry
VA CT Healthcare Center S116A2, 950 Campbell Avenue
West Haven, CT 06516
United States